View Item 

Show simple item record

Recent Observations Regarding Interferon, Keratinocytes and Lymphocytes In vitro and In vivo

dc.contributor.authorNickoloff, Brian J.en_US
dc.date.accessioned2015-05-04T20:36:39Z
dc.date.available2015-05-04T20:36:39Z
dc.date.issued1988-04en_US
dc.identifier.citationNickoloff, Brian J. (1988). "Recent Observations Regarding Interferon, Keratinocytes and Lymphocytes In vitro and In vivo." The Journal of Dermatology 15(2): 93-98.en_US
dc.identifier.issn0385-2407en_US
dc.identifier.issn1346-8138en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/111185
dc.publisherWiley Periodicals, Inc.en_US
dc.titleRecent Observations Regarding Interferon, Keratinocytes and Lymphocytes In vitro and In vivoen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelDermatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/111185/1/jde03658.pdf
dc.identifier.doi10.1111/j.1346-8138.1988.tb03658.xen_US
dc.identifier.sourceThe Journal of Dermatologyen_US
dc.identifier.citedreferenceHaglund S, Lundguist PG, Cantell K: Interferon therapy in juvenile laryngeal papillomatosis, Arch Otolaryngeal, 107: 327 – 332, 1981.en_US
dc.identifier.citedreferenceNathan CF, Kaplan G, Levis WR, Nusrat A, Witmer MD, Sherman SA, Job CK, Horowitz CR, Steinman RM, Cohn ZA: Local and systemic effects of intradermal recombinant interferon‐gamma in patients with lepromatous leprosy, N Eng J Med, 315: 6 – 15, 1986.en_US
dc.identifier.citedreferenceMorhenn VB, Pregerson‐Rodan K, Mullen R, Wood GS, Nickoloff BJ, Farber EM: The use of recombinant gamma interferon administered intramuscularly in the treatment of psoriasis, Arch Dermatol, 123: 1633 – 1637, 1987.en_US
dc.identifier.citedreferenceQuesada JR, Gutterman JU: Psoriasis and alpha‐interferon, Lancet, 1: 1466 – 1468, 1986.en_US
dc.identifier.citedreferenceEdwards L, Levine N, Weidner M, Piepkorn M, Smiles K: Effect of intralesional alpha interferon on actinic keratoses, Arch Dermatol, 122: 779 – 782, 1986.en_US
dc.identifier.citedreferenceOdgren P, Borgstrom S, Ionsson PE, Lindstrom C, Sjogren HO: Metastatic malignant melanoma: regression induced by combined treatment with alpha interferon and cimetidine, Int J Cancer, 32: 657 – 665, 1983.en_US
dc.identifier.citedreferenceCragan ET, Ahman DL, Green SJ, Lang HJ, Fyrtak S, O'Fallon JR, Intri LM: Phase II study of low dose recombinant alpha interferon in disseminated malignant melanoma, J Clin Oncol, 2: 1002 – 1005, 1984.en_US
dc.identifier.citedreferenceKirkwood JM, Ernstoff MS, Davis CA, Reiss M, Ferraresi R, Rudnick SA: Comparison of intramuscular and intravenous recombinant alpha‐2 interferon in melanoma and other cancers, Ann Int Med, 103: 32 – 36, 1985.en_US
dc.identifier.citedreferenceBunn PA, Foon KA, Ihde DC, Sherwin S, Oldham R: Recombinant leukocyte A interferon: an active agent in advanced cutaneous T‐cell lymphoma, Ann Int Med, 101: 484 – 487, 1984.en_US
dc.identifier.citedreferenceRapp F, Wrzos H: Synergistic effect of human leukocyte interferon and Nonoxynol 9 against herpes simplex virus Type 2, antimicrob, Agents Chemo, 28: 449 – 451, 1985.en_US
dc.identifier.citedreferenceYancey KB, Smith JG: Interferon: status in treatment of skin disease, J Am Acad Dermatol, 3: 585 – 589, 1980.en_US
dc.identifier.citedreferenceNickoloff BJ: Interferons and psoriasis—1987 perspective, Dermatologica, 175: 1 – 4, 1987.en_US
dc.identifier.citedreferenceNickoloff BJ: New strategies for psoriasis therapy, Cutis, 37: 421 – 423, 1986.en_US
dc.identifier.citedreferencePatterson JA, Edelson RL: Interaction of T cells with the Epidermis, Br J Dermatol, 107: 117 – 122, 1982.en_US
dc.identifier.citedreferenceStreilein JW: Skin‐associated lymphoid tissues (SALT): origins and functions, J Invest Dermatol, 80: 12s – 16s, 1983.en_US
dc.identifier.citedreferenceKatz SI: The skin as an immunologic organ: a tribute to Marion B Sulzberger, J Invest Dermatol, 13: 530 – 536, 1985.en_US
dc.identifier.citedreferenceRubenfeld MR, Silverstone AE, Knowles DM, Halper JP, De Sostoa A, Fenoglio CM, Edelson RL: Induction of lymphocyte differentiation by epidermal cultures, J Invest Dermatol, 77: 221 – 228, 1981.en_US
dc.identifier.citedreferenceChu A, Patterson J, Goldstein G, Berger C, Takezaki S, Edelson RL: Thymopietin‐like substance in human skin, J Invest Dermatol, 78: 330 – 334, 1982.en_US
dc.identifier.citedreferenceLuger TA, Stadler BM, Katz SI, Oppenheim JJ: Epidermal cell (keratinocyte)‐derived thymocyte activating factor (ETAF), J Immunol, 127: 1493 – 1498, 1981.en_US
dc.identifier.citedreferenceSauder DN, Carter C, Katz SI, Oppenheim JJ: Epidermal cell production of thymocyte activating factor, Clin Res, 29: 285 a, 1981.en_US
dc.identifier.citedreferenceStingl G, Tamaki K, Katz SI: Origin and function of epidermal Langerhans cells, Immun Rev, 53: 149 – 174, 1980.en_US
dc.identifier.citedreferenceIsaacs A, Lindermann J: Virus interference I, The interferons, Proc R Soc Lond (Biol), 147: 258 – 272, 1957.en_US
dc.identifier.citedreferencePreble OT, Friedman RM: Interferon‐induced alterations in cells: relevance to viral and non‐viral diseases, Lab Invest, 49: 4 – 19, 1983.en_US
dc.identifier.citedreferenceBasham TY, Nickoloff BJ, Merigan TC, Morhenn BV: Recombinant gamma interferon induces HLA‐DR expression on cultured human keratinocytes, J Invest Dermatol, 83: 88 – 92, 1984.en_US
dc.identifier.citedreferenceBasham TY, Nickoloff BJ, Merigan TC, Morhenn VB: Recombinant gamma interferon differentially regulates class II antigen expression and biosynthesis on cultured human keratinocytes, J Interfer Res, 5: 23 – 27, 1985.en_US
dc.identifier.citedreferenceMorhenn VB, Nickoloff BJ, Mansbridge JN: Induction of the synthesis of triton soluble proteins in human keratinocytes by gamma interferon, J Invest Dermatol, 85: 27 – 29, 1985.en_US
dc.identifier.citedreferenceNickoloff BJ, Basham TY, Merigan TC, Morhenn VB: Antiproliferative effects of recombinant alpha and gamma interferons on cultured human keratinocytes, Lab Invest, 51: 697 – 701, 1984.en_US
dc.identifier.citedreferenceNickoloff BJ, Mahrle G, Morhenn VB: The ultrastructural effects of recombinant gamma interferon on cultured human keratinocytes, J Ultrast Res, 10: 17 – 21, 1984.en_US
dc.identifier.citedreferenceNickoloff BJ, Basham TY, Merigan TC, Morhenn VB: Immuno‐modulatory and antiproliferative effect of recombinant alpha, beta and gamma interferons on cultured human malignant squamous cell lines SCL‐1 and SW‐1271, J Invest Dermatol, 84: 487 – 490, 1985.en_US
dc.identifier.citedreferenceVolc‐Platzer B, Majdic O, Knapp W, Wolff K, Hinterberger W, Lechner K, Stingl G: Evidence of HLA‐DR antigen biosynthesis by human keratinocytes in disease, J Exp Med, 159: 784, 1984.en_US
dc.identifier.citedreferenceYaar M, Karassik RL, Schnipper L, Gilchrest BA: Effects of alpha and beta interferons on cultured human keratinocytes, J Invest Dermatol, 85: 70 – 74, 1985.en_US
dc.identifier.citedreferenceStadler R, Muller R, Orfanos CE: Effect of recombinant alpha A interferon on DNA synthesis and differentiation of human keratinocytes in vitro, Br J Dermatol, 114: 273 – 277, 1986.en_US
dc.identifier.citedreferenceNickoloff BJ, Basham TY, Merigan TC, Morhenn VB: Keratinocyte class II histocompatibility antigen expression, Br J Dermatol, 112: 373, 1985.en_US
dc.identifier.citedreferenceNickoloff BJ, Basham TY, Torseth J, Merigan TC, Morhenn VB: Human keratinocyte‐lymphocyte reactions in vitro, J Invest Dermatol, 87: 171 – 178, 1986.en_US
dc.identifier.citedreferenceInaba K, Steinman RM: Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen‐presenting cell) requirements for growth and lymphokine release, J Exp Med, 160: 1717 – 1735, 1984.en_US
dc.identifier.citedreferenceAubock J, Romani N, Grubauer G, Fritsch P: HLA‐DR expression on keratinocytes is a common feature of diseased skin, Br J Dermatol, 114: 465 – 472, 1986.en_US
dc.identifier.citedreferenceRoberts LK, Krueger GG, Daynes RA: Correlation between the inducible keratinocyte expression of Ia and the movement of Langerhans cells into the epidermis, J Immunol, 134: 3781 – 3784, 1985.en_US
dc.identifier.citedreferenceShiohara T, Lerner AB: Cytologic changes induced by local transfer of Ia‐reactive T cell clones, J Invest Dermatol, 82: 406, 1984.en_US
dc.identifier.citedreferenceSchnipper LE, Levin M, Crumpacker CS, Gilchrest BA: Viral replication and induction of interferon in human epidermal keratinocytes following infection with herpes simples virus, J Invest Dermatol, 82: 94 – 96, 1984.en_US
dc.identifier.citedreferenceTorseth JW, Nickoloff BJ, Basham TY, Merigan TC: Interferon beta produced by keratinocytes in human cutaneous herpes simplex infection, J Infect Dis, 155: 641 – 648, 1987.en_US
dc.identifier.citedreferenceTorseth JW, Merigan, TC: Significance of local gamma interferon in recurrent herpes simplex infection, J Infect Dis, 153: 979 – 984, 1986.en_US
dc.identifier.citedreferenceHayashi Y, Asrelian L: Immunity to herpes simplex virus type 2: viral and antigen presenting capacity of epidermal cells and its impairment by ultraviolet irradiation, J Immunol, 136: 1087 – 1092, 1986.en_US
dc.identifier.citedreferenceMerigan TC, Rand KH, Pollard RB: Human leukocyte interferon for the treatment of herpes zoster in patients with cancer, N Eng J Med, 298: 981 – 987, 1978.en_US
dc.identifier.citedreferenceArvin AM, Kushner JH, Feldman S, Bachner RL, Hammond D, Merigan TC: Human leukocyte interferon for the treatment of varicella in children with cancer, N Eng J Med, 306: 761 – 765, 1982.en_US
dc.identifier.citedreferenceShalev Y, Berrebi A, Green L, Levin S, Frumkin A, Hurwitz N, Bertwich Z: Progressive cutaneous herpes simples infection in acute myeloblastic leukemia: successful treatment with interferon and cytarabine, Arch Dermatol, 120: 922 – 926, 1984.en_US
dc.identifier.citedreferenceVance JC, Brit BJ, Hassen RC, Reichman RC, McEwen C, Hatch KD, Berman B, Tanner DJ: Intralesional recombinant alpha‐2 interferon for the treatment of patients with condyloma accuminatum or verruca plantaris, Arch Dermatol, 122: 272 – 277, 1986.en_US
dc.identifier.citedreferenceNiimura M: Intralesional human fibroblasts interferon in common warts, J Dermatol (Tokyo), 10: 217 – 220, 1983.en_US
dc.identifier.citedreferenceVesterinen E, Meyer B, Purola E: Treatment of vaginal flat condyloma with interferon cream, Lancet, 2: 157, 1982.en_US
dc.identifier.citedreferenceSchonfeld A, Schattner A, Crespi M, Doerner T, Revel M: Intramuscular human interferon‐beta injections in treatment of condylomata accuminata, Lancet, 2: 1038 – 1041, 1984.en_US
dc.identifier.citedreferenceAndophy EJ, Dvoretzky I, Malaish AE, Wallace HJ, Lowy DR: Response of warts in epidermodysplasia verruciformis to treatment with systemic and intralesional alpha interferon, J Am Acad Dermatol, 11: 197 – 202, 1984.en_US
dc.identifier.citedreferenceGross G, Roussaki A, Schopf E, Papendick U: Successful treatment of condylomata accuminata and bowenoid papulosis with subcutaneous injection of low dose recombinant alpha interferon, Arch Dermatol, 122: 749 – 750, 1986.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jde03658.pdf
Size:
465.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.